YOSHIHARA; Keiichi

Patent Applications and Registrations

Patent applications and USPTO patent grants for YOSHIHARA; Keiichi.The latest application filed is for "thrombin-carrying hemostatic sheet".

Company Profile

0.7.17

YOSHIHARA; Keiichi - Chuo-ku JP
Yoshihara; Keiichi - Kanagawa JP
Yoshihara; Keiichi - Tokyo JP
Yoshihara; Keiichi - Shizuoka JP
Yoshihara; Keiichi - Shizuoka-ken JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thrombin-carrying Hemostatic Sheet App 20220143263 - OGINO; Makoto ; et al.	2022-05-12
Content management system, management content generating method, management content play back method, and recording medium Grant 10,410,677 - Yamaji , et al. Sept	2019-09-10
Content management system, management content generation method, management content reproduction method, program and recording medium Grant 9,721,613 - Yamaji , et al. August 1, 2	2017-08-01
Content Management System, Management Content Generating Method, Management Content Play Back Method, And Recording Medium App 20160078904 - YAMAJI; Kei ; et al.	2016-03-17
Content Management System, Management Content Generation Method, Management Content Reproduction Method, Program And Recording Medium App 20150221343 - YAMAJI; Kei ; et al.	2015-08-06
Pharmaceutical Composition Containing Mirabegron App 20150031734 - Kasashima; Yuki ; et al.	2015-01-29
Sustained release pharmaceutical composition Grant 8,197,846 - Sako , et al. June 12, 2	2012-06-12
Methods For Maintaining Effective Plasma Concentrations Of A Pharmaceutical App 20120088838 - Sako; Kazuhiro ; et al.	2012-04-12
Sustained release pharmaceutical composition Grant 8,128,958 - Sako , et al. March 6, 2	2012-03-06
Sustained Release Formulation For Tacrolimus App 20110281906 - Kondo; Hiromu ; et al.	2011-11-17
Controlled Release Dosage Form of Tacrolimus App 20110142933 - KOJIMA; Hiroyuki ; et al.	2011-06-16
Solid Pharmaceutical Composition Containing Solifenacin Amorphous Form App 20100273825 - WAKO; Yuko ; et al.	2010-10-28
Method for improving adsorption of a drug from ethylene oxide derivative Grant 7,816,373 - Yoshihara , et al. October 19, 2	2010-10-19
Sustained release formulation for tacrolimus App 20090011018 - Kondo; Hiromu ; et al.	2009-01-08
Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug App 20080221047 - Yoshida; Takatsune ; et al.	2008-09-11
Controlled release dosage form of tacrolimus App 20080181947 - Kojima; Hiroyuki ; et al.	2008-07-31
Pharmaceutical Composition for Treatment of Tear and Salivary Fluid Drying App 20080131511 - Okada; Yohei ; et al.	2008-06-05
Pharmaceutical composition for treatment of tear and salivary fluid drying App 20070105934 - Okada; Yohei ; et al.	2007-05-10
Method for improving adsorption of a drug from ethylene oxide derivative Grant 7,153,524 - Yoshihara , et al. December 26, 2	2006-12-26
Method For Improving Adsorption Of A Drug From Ethylene Oxide Derivative App 20060204579 - Yoshihara; Keiichi ; et al.	2006-09-14
Method for improving adsorption of a drug from ethylene oxide derivative App 20050100607 - Yoshihara, Keiichi ; et al.	2005-05-12
Sustained release pharmaceutical composition App 20050100602 - Sako, Kazuhiro ; et al.	2005-05-12
Sustained release pharmaceutical composition App 20050100603 - Sako, Kazuhiro ; et al.	2005-05-12
Stable pharmaceutical composition for oral use Grant 6,562,375 - Sako , et al. May 13, 2	2003-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.